Acadia Pharmaceuticals Inc. | ACAD

Daily Technical Analysis of Acadia Pharmaceuticals Inc.

Investors didn't show much interest in one Acadia Pharmaceuticals way or another today. It hasn't moved too much today but is slightly down, it lost -0.70% since yesterday.

It looks like Acadia Pharmaceuticals isn't currently at a very decisive point in regards to support/resistance levels. Acadia Pharmaceuticals hasn't established a very strong momentum in either direction over the last 3 months. We'll see if a stronger consensus among market participants emerges. ACAD might find some support at the 12.75 level, buyers might push the price back up from here. But it's not very clear what will happen.

Last analyzed on 2024-03-17

Analyst Ratings for Acadia Pharmaceuticals By Price Target And Rating

Acadia Pharmaceuticals has an overall positive view by the analysts. The current Analysts Sentiment Score is 196.40. Most companies range between (-200 to 200).

Here's a break down of the latest rating changes. Needham & Company LLC dropped their price target by -11.11% to $32.00 on 2024-03-12. Mizuho downgraded from Buy to Neutral on 2024-03-12 and decided to decrease their price target by -35.9% down to $25.00. JPMorgan Chase & Co. provided a price target decease of -9.38% to $29.00 from $32.00 on 2024-03-01. Royal Bank of Canada announced a lowering of their price target to $35.00 from $36.00 on 2024-02-28. Cantor Fitzgerald announced that they are reiterating a rating of Overweight on 2024-02-28 and they set their price target at $42.00. On 2024-02-28 HC Wainwright reiterated their rating of Buy and added a price target of $33.00. JMP Securities reiterated a rating of Market Outperform on 2024-02-07 and added a price target of $42.00. Oppenheimer reiterated a rating of Market Perform on 2024-02-05 and added a price target of $25.00. Robert W. Baird announced that they are initiating coverage with a rating of Outperform on 2024-01-30 and provided a price target of $40.00. On 2023-12-19 Morgan Stanley upgraded Acadia Pharmaceuticals from Equal Weight to Overweight and moved up their price target to $40.00 which is a 29.03% increase.

Company	Ratings Score ? Composite analyst sentiment score	Positive Ratings	Negative Ratings	Boost Price Target	Lower Price Target
ACAD	196.40	287.78	-66.15	248.53	-77.35

Earnings Per Share (EPS) Estimates By Year and Quarter

(updated 2024-03-30)

Company	YOY Growth Score (typical -20 to +20)	Revision Directions (-6 to +6)
ACAD	0.00	0.00

Short interest for Acadia Pharmaceuticals

We take into account several different measures of short interest to create a composite score. These measures are shown in the chart below. Short selling is when investors are betting against a stock. We compile these factors to create a dynamic Short Score - this can indicate poor sentiment, internal problems with a company or industry and the anticipation of future price declines. We look at the short interest percent, days to cover, the rate of change and total shares sold short.

Company	Short Score (typical 1-15) ? We take into account several different measures and attributes of short interest to create a composite sentiment score. typical range (0 - 30)	Short Interest	Days to Cover	Rate of Change	Shares Short
ACAD	4.44	%4.59252	4.7	-7.326	7540000

How Acadia Pharmaceuticals compares to the broader Healthcare sector and the more specific Biotechnology industry

Segment	Count	1 Day%	5 Day	1 Month	3 Month	6 Month	1 Year	RSI	3mo S-momo ? Smooth Momentum is our proprietary technical indicator that looks for momentum with the greatest consistency and steady velocity. We have penalized dramatic swings and fluctuations. If the momentum is too high and an asset spikes upward, this is often unreliable and collapses back down. But the smoothed momentum provides the highest probability of continuing into the near future with the same directional rate of change. Several complex factors are weighted by neural nets to maximize probabilistic accuracy. It works the same with positive or negative directions.	6mo S-momo	1yr S-momo	Resistance ? Support and Resistance levels are determined by previous high and low points. You may be familiar with traders drawing lines across charts where several peaks or valleys occur in the same range. This helps us understand the trading range of an asset where the market doesn't perceive it to be worth more or less than a certain price level. When it nears the boundaries of this range the probability of reversal can increase. Our neural nets create scores for this measure based on many factors such as the frequency, recency, size, consistency, etc of previous reversal points.	Support	Demark Sell ? Demark 9 indicators are designed to look for exhaustion in the selling or buying trend which can often be predictive of a reversal point. This indicator is triggered when there are 9 consecutive days where the closing price is higher/lower than the closing price 4 days ago. Like all indicators, it is best used in combinations with other factors.	Demark Buy	Short Interest	Analysts Ratings ? We track several different measures of analyst sentiment including ratings and price targets. To create a composite Analyst Sentiment Score, we weight several factors such as the recent rate of change which can be more predictive than the absolute level. We also weight each analyst's opinion based on their historic accuracy. We built in a time decay function to ensure that the rating reflects the current sentiment levels. Typical range (-80 to +80)
Biotechnology Show Me Companies With: S-Momentum: Highest \| Lowest At Bottom Support At Top Resistance RSI Highest \| Lowest 1 Day Growth: Highest \| Lowest 5 Day Growth: Highest \| Lowest 1 Month Growth: Highest \| Lowest 6 Month Growth: Highest \| Lowest List All Stocks	104	-2.59	-6.57	-10.18	2.52	35.91	11.73	37.26	33.18	13.74	12.82	-13905.94	-11063.75	3.37	24.04	9.58	70.99
Healthcare Show Me Companies With: S-Momentum: Highest \| Lowest At Bottom Support At Top Resistance RSI Highest \| Lowest 1 Day Growth: Highest \| Lowest 5 Day Growth: Highest \| Lowest 1 Month Growth: Highest \| Lowest 6 Month Growth: Highest \| Lowest List All Stocks	247	-1.66	-4.90	-9.06	-1.74	20.30	1.72	41.55	31.33	10.68	11.04	-12888.05	-11534.39	4.96	17.31	6.93	50.93

Social Sentiment for Acadia Pharmaceuticals

Social Sentiment is an aggregation of several different factors such as news, articles, blogs, user content, ratings, etc. Which is shown in the chart below. It may become predictive of a reversal if price and the sentiment diverge. Broader market forces may push prices up or down but if market participants maintain a different view on a specific stock, it may be taken as an opportunity to buy or sell in those cases.

Ticker	Social Sentiment(1-10)
ACAD

Companies with the highest correlation to Acadia Pharmaceuticals

Company	Score	1 Day%	5 Day	1 Month	3 Month	6 Month	1 Year	RSI	3mo S-momo ? Smooth Momentum is our proprietary technical indicator that looks for momentum with the greatest consistency and steady velocity. We have penalized dramatic swings and fluctuations. If the momentum is too high and an asset spikes upward, this is often unreliable and collapses back down. But the smoothed momentum provides the highest probability of continuing into the near future with the same directional rate of change. Several complex factors are weighted by neural nets to maximize probabilistic accuracy. It works the same with positive or negative directions.	6mo S-momo	1yr S-momo	Resistance ? Support and Resistance levels are determined by previous high and low points. You may be familiar with traders drawing lines across charts where several peaks or valleys occur in the same range. This helps us understand the trading range of an asset where the market doesn't perceive it to be worth more or less than a certain price level. When it nears the boundaries of this range the probability of reversal can increase. Our neural nets create scores for this measure based on many factors such as the frequency, recency, size, consistency, etc of previous reversal points.	Support	Short Interest Score
XNCR \| Xencor, Inc.	0.86	-0.63	-7.47	-16.92	-4.63	1.34	-32.92	41	4.75	5.27	1.01	-10748.00	-2169.32	15.4823
DNLI \| Denali Therapeutics Inc.	0.75	-1.31	-9.09	-20.95	-2.98	-14.12	-33.55	44	-10.54	-23.64	-26.73	-17158.84	-1907.18	11.2371
SAGE \| Sage Therapeutics, Inc	0.69	3.70	-15.58	-34.73	-50.83	-32.16	-72.52	27	-22.06	-22.77	-15.93	-51237.60	-1298.12	12.6533
RCKT \| Rocket Pharmaceuticals, I	0.65	-0.84	-2.94	-15.27	-15.69	39.93	21.97	38	12.18	32.42	36.89	-2746.04	-17665.95	9.12889

Top 3 correlating companies

See full charts for all peers

Research

Estimates

Ratings

Short Interest

Smart Money

Options

Financials

Social

Misc